Senior Staff Scientist
Stephan, biochemist, did his PhD (2002) in molecular biology with the Pr. W. Schlegel (University of Geneva). After a first postdoc (2003-07), working on the function of BARD1 isoforms in ovarian cancer (Dr. I. Irminger-Finger, University Hospitals of Geneva); he did a second post-doc (2008-13) with Dr. A. Moodycliffe and Pr. D. Hohl (University Hospital of Lausanne) to investigate the role of CD1d in UV-induced skin inflammation and cancer.
Lou obtained a master degree from the faculty of Science, University of Geneva. She is currently doing her PhD in the Labidi-Galy lab, working on the impact of menopause on breast cancer in BRCA1 carriers.
Nawel, biochemist, did her PhD with Dr. A. De Agostini (Department of Pathology and Immunology) at the Faculty of Medicine, University of Geneva. She investigated the role of aHSPG post biosynthetic modification and its implication on endometrial cancer invasion and angiogenesis (2015-2020). She is currently doing her postdoc working on targeting BRCA mutated ovarian cancer resistant to PARP inhibitors.
Clothilde is a visiting master student from the University of Poitiers in France. She is doing her master internship at the Labidi-Galy lab exploring new immunotherapy approaches toward mucinous ovarian carcinoma.
Visiting BSc Student
Jonathan obtained a Bachelor’s degree from Swansea University Medical School in UK. He is currently undertaking internship in the Labidi-Galy lab, investigating the impact of menopause on breast cancer in BRCA1 carriers.